Delta 9 Cannabis Inc. (DN.TO) Research
Delta 9 Cannabis Inc. is a diversified enterprise operating across various segments of the cannabis industry. Its subsidiary, Delta 9 Bio-Tech Inc., handles the cultivation, processing, extraction, and distribution of both medicinal and recreational cannabis products, managing both wholesale and retail channels. The product portfolio spans dried cannabis flower, pre-rolled joints, dried sift, various oils, and a range of extracted and derivative offerings; notably, they also provide decontamination pods. Furthermore, Delta 9 supplies grow pods and live cannabis plants to other businesses, including those already licensed and those awaiting licensure. Beyond product sales, the company runs a medical clinic where physicians offer consultations to patients looking for a medical recommendation for cannabis prescriptions. As of April 20, 2022, Delta 9 operated a network of 35 branded retail outlets throughout the Canadian Prairies. Established in 2001, its corporate headquarters are located in Winnipeg, Canada.
Market snapshot
- Symbol
- DN.TO
- Price
- $0.01
- Day change
- -50.00%
- Market cap
- $1.5M
- P/E ratio
- -0.05x
- 52-week range
- 0.005-0.07
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
Peer companies
Open Delta 9 Cannabis Inc. (DN.TO) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.